Clinical Trials Logo

Recurrent Neoplasm clinical trials

View clinical trials related to Recurrent Neoplasm.

Filter by:
  • None
  • Page 1

NCT ID: NCT02566421 Terminated - Clinical trials for Stage IV Non-Small Cell Lung Cancer

Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

Start date: October 2015
Phase: N/A
Study type: Interventional

This pilot clinical trial studies patients' genomic sequencing in determining specific treatments, also called Precision Medicine, in patients with cancer that has spread to other parts of the body (metastatic) and/or cannot be removed by surgery. Examining the genetic code of a patient's tumor, a mutation (a change in the deoxyribonucleic acid [DNA] sequence of a cell or gene) may be identified and matched with available treatment that targets the mutated gene or an alternative treatment that may provide benefit for the patient with the mutation identified. Precision medicine may impacts patient's response to treatment by targeting specific mutations and may increase survival and improve quality of life.